Molecular Partners AG
(NASDAQ:MOLN)
$4.29
-0.19 (-4.17%)
Open: 1:21 PM
MOLN Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MOLN Stock Price Today
Molecular Partners AG (MOLN) stock declined over -4.18% intraday to trade at $4.2928 a share on NASDAQ. The stock opened with a loss of -16.52% at $3.74 and touched an intraday high of $3.74, falling -4.18% against the last close of $4.48. The Molecular Partners AG in stock market went to a low of $3.74 during the session.
MOLN Stock Snapshot
$4.48
Prev. Close
141.02 Million
Market Cap
$3.74
Day Low
$3.74
Open
N/A
Number of Shares
$3.74
Day High
N/A
P/E ratio
-1.93
EPS (TTM)
6.29
Cash Flow per Share
N/A
Free Float in %
5.97
Book Value
578.00
Volume
MOLN Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.81
Sales or Revenue$8.7 Million
5Y Sales Change352.47%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Peers
Frequently Asked Questions
What is the current Molecular Partners AG (MOLN) stock price?
Molecular Partners AG (NASDAQ: MOLN) stock price is $4.29 in the last trading session. During the trading session, MOLN stock reached the peak price of $3.74 while $3.74 was the lowest point it dropped to. The percentage change in MOLN stock occurred in the recent session was -4.18% while the dollar amount for the price change in MOLN stock was -$0.19.
MOLN's industry and sector of operation?
The NASDAQ listed MOLN is part of Biotechnology industry that operates in the broader Healthcare sector. Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus.
Who are the executives of MOLN?
Mr. Michael Pitzner
Gen. Counsel, Compliance Officer & Senior Vice President of Legal
Mr. Andreas Emmenegger E.M.B.A.
Advisor
Dr. Patrick Amstutz Ph.D.
Co-Founder, Chief Executive Officer, Member of Management Board & Director
Mr. Thomas Schwerzmann
Vice President of HR
How MOLN did perform over past 52-week?
MOLN's closing price is 0.19% higher than its 52-week low of $3.61 where as its distance from 52-week high of $7.36 is -0.18%.
How many employees does MOLN have?
Number of MOLN employees currently stands at N/A. MOLN operates from Wagistrasse 14, Schlieren, 8952, CH.
Link for MOLN official website?
Official Website of MOLN is: https://www.molecularpartners.com
How do I contact MOLN?
MOLN could be contacted at phone #41 44 755 77 00 and can also be accessed through its website. MOLN operates from Wagistrasse 14, Schlieren, 8952, CH.
How many shares of MOLN are traded daily?
MOLN stock volume for the day was 578.00 shares. The average number of MOLN shares traded daily for last 3 months was 5.34 Thousands.
What is the market cap of MOLN currently?
The market value of MOLN currently stands at $141.02 Million with its latest stock price at $4.29 and N/A of its shares outstanding.